FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in the Nordics

Biotech startups in the Nordics

Updated 16 Nov 2026

Reset
Biotech startups in the Nordics
One-time CSV
  • 198 funded companies, 132 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~nordics.csv198 rows × 18 columns
CompanyCityLast roundAmountDate
ADCendoCopenhagenSeries C$75.0M2026-04-14
MavatarStockholmSeed$3.9M2024-09-01
Onego BioHelsinkiSeries B$28.0M2026-10-26
MoleculentSolnaSeries A$20.0M2026-04-30
Asgard TherapeuticsLundSeries A$32.6M2024-03-14
AgainCopenhagenSeries A$43.1M2024-07-17
Octarine BioCopenhagenSeries A$5.9M2026-01-22
InvertCopenhagenSeed$20.1M2024-07-10

8 rows of the CSV in 5 of its 18 columns.

198
Startups
$2.4B
Total raised
31
Funded in the last 12 months
$473.7M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 198
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Onego Bio Onego Bio produces egg protein through fermentation as a food ingredient. Biotech Helsinki, Finland Series B $28.0M 2026-10-26 $100.6M European Innovation Council, Business Finland, Tesi +2 11 to 50 2022
Pixelgen Technologies Pixelgen Technologies develops technologies for biomedical research and diagnostics. Biotech Stockholm, Sweden Series B $15.5M 2026-08-20 $43.5M Industrifonden, Navigare Ventures, Colibri Ventures +1 11 to 50 2020
Alcolase Alcolase is a Danish life science start-up developing treatments for alcohol flushing. Biotech Copenhagen, Denmark Seed $1.7M 2026-05-18 $2.6M Antler 1 to 10 2021
Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021
ADCendo ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. Biotech Copenhagen, Denmark Series C $75.0M 2026-04-14 $324.6M RA Capital Management, Novo Holdings, Gilde Healthcare +2 51 to 100 2017
Cellevate Cellevate develops cell culture systems for biotech research and production. Biotech Lund, Sweden Seed $2.2M 2026-03-30 $12.1M European Innovation Council, Industrifonden, Onsight Ventures +1 11 to 50 2014
ENZIDIA ENZIDIA develops enzyme acceleration technology for biomanufacturing. Biotech Kongens Lyngby, Denmark Angel $241K 2026-03-16 $865K Innovation Fund Denmark 1 to 10 2024
Biomia Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. Biotech Lyngby, Denmark Seed $3.0M 2026-02-09 $3.0M BlueYard Capital, Amino Collective, Nucleus Capital 1 to 10 2022
Octarine Bio Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. Biotech Copenhagen, Denmark Series A $5.9M 2026-01-22 $15.5M MassChallenge, Vaekstfonden, Unconventional Ventures +2 11 to 50 2018
Seaqure Labs AB Seaqure Labs develops mycoprotein-based alternatives to current unsustainable methods used in aquaculture. Biotech Gothenburg, Sweden Pre-seed $546K 2025-08-21 $1.1M Chalmers Ventures AB 1 to 10 2024
Trackpaw Scientific TrackPaw Scientific develops and commercializes a technology platform for accelerating medication development. Biotech Lund, Sweden Seed $2.7M 2025-08-18 $3.1M Almi Invest, I Love Lund, LU Holding 1 to 10 2022
SNIPR Biome SNIPR Biome develops discovery-stage biotech treatments for microbial diseases. Biotech Copenhagen, Denmark Series B $40.9M 2025-08-07 $103.4M Wellington Partners, Bill & Melinda Gates Foundation, EQT Life Sciences +1 11 to 50 2017
Single Technologies Single Technologies develops a 3-D DNA sequencing system. Artificial intelligence Stockholm, Sweden Seed $11.6M 2025-06-24 $28.6M Almi Invest, Sting, KTH Holding +1 11 to 50 2014
Droplet IV Droplet IV develops automated technology for intravenous infusion therapy to reduce nursing workload. Biotech Kongens Lyngby, Denmark Seed $2.0M 2025-06-17 $4.0M MedTech Innovator, BioInnovation Institute Venture Lab, BioInnovation Institute Venture House 1 to 10 2022
TILT Biotherapeutics TILT Biotherapeutics develops therapies that enable the immune system to attack tumors. Biotech Helsinki, Finland Series B $25.3M 2025-05-13 $71.1M European Innovation Council, Business Finland, Lifeline Ventures +1 11 to 50 2013
MedTrace Pharma MedTrace Pharma helps doctors diagnose critically ill patients faster and more accurately. Biotech Lyngby, Denmark Series F $11.1M 2025-05-12 $63.4M European Innovation Council, Vaekstfonden, ATP +1 11 to 50 2015
Commit Biologics Commit Biologics develops a novel immunotherapy platform for treating cancer. Biotech Aarhus, Denmark Seed $5.7M 2025-01-28 $23.7M Novo Holdings, Innovation Fund Denmark, Bioqube Ventures 11 to 50 2021
Mavatar Mavatar develops AI and digital twin technology to reduce medication errors. Artificial intelligence Stockholm, Sweden Seed $3.9M 2024-09-01 Collinstar Capital 11 to 50 2021
Nygen Analytics Nygen Analytics provides cloud-based tools for cost-effective analysis of single-cell genomic data. Biotech Lund, Sweden Seed $734K 2024-08-29 $734K Fåhraeus Startup and Growth, SmiLe Inject Capital 1 to 10 2021
Arcana Bio Arcana Bio applies proteomics and AI to develop biotech diagnostics delivered as software. Biotech Reykjavík, Iceland Seed $554K 2024-08-29 $853K New Business Venture Fund 1 to 10 2018
NADMED NADMED brings a new NAD metabolite measurement technology to market. Biotech Helsinki, Finland Series A $3.9M 2024-08-22 Business Finland, Voima Ventures, Nordic Science Investments 11 to 50 2022
Again Again is a carbon utilization company that converts carbon emissions into valuable chemicals. Biotech Copenhagen, Denmark Series A $43.1M 2024-07-17 Google Ventures, HV Capital, ACME Capital +1 11 to 50 2020
Invert Invert provides AI-driven software that supports real-time decisions in bioprocessing. Artificial intelligence Copenhagen, Denmark Seed $20.1M 2024-07-10 $20.6M Y Combinator, Giant Ventures 11 to 50 2021
BrainZell BrainZell uses stem cell-based models that more closely match the human brain than animal models. Biotech Stockholm, Sweden Seed $1.5M 2024-06-03 Sting, Norrsken Evolve 1 to 10 2020
Enifer Enifer produces mycoprotein by fungal fermentation, upcycling agrifood industry byproducts. Biotech Espoo, Finland Series B $16.2M 2024-05-23 Tesi, Finnvera Venture Capital, Voima Ventures +1 11 to 50 2020
Reshape Biotech Reshape Biotech builds lab robots that automate routine microbiology tasks like plate filling and image analysis. Artificial intelligence Kongens Lyngby, Denmark Series A $20.0M 2024-04-09 Y Combinator, FundersClub, Astanor Ventures 11 to 50 2018
Asgard Therapeutics Asgard Therapeutics is a biotechnology company developing new therapies. Biotech Lund, Sweden Series A $32.6M 2024-03-14 $39.6M Novo Holdings, Industrifonden, Boehringer Ingelheim Venture Fund +2 11 to 50 2018
Infinited Fiber Company Infinited Fiber Company works to make circular fashion and textiles an everyday reality. Biotech Espoo, Finland Series B $29.5M 2024-03-08 Business Finland, European Commission 51 to 100 2016
Calluna Pharma Calluna Pharma develops first-in-class therapies that target chronic inflammation and fibrosis at their source. Biotech Oslo, Norway Series A $81.4M 2024-01-23 Forbion Capital Partners, Investinor, Sarsia +1 11 to 50 2024
Hoba Therapeutics Hoba Therapeutics develops a new therapeutic protein for treating neuropathic pain. Biotech Copenhagen, Denmark Series A $24.8M 2023-12-11 European Innovation Council, EIC Accelerator, Novo Holdings +2 1 to 10 2016

Table 1. Biotech startups in the Nordics: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 198.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 ADCendo ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. Biotech Copenhagen, Denmark Series C $75.0M 2026-04-14 $324.6M RA Capital Management, Novo Holdings, Gilde Healthcare +2 51 to 100 2017
2 Onego Bio Onego Bio produces egg protein through fermentation as a food ingredient. Biotech Helsinki, Finland Series B $28.0M 2026-10-26 $100.6M European Innovation Council, Business Finland, Tesi +2 11 to 50 2022
3 Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021
4 Pixelgen Technologies Pixelgen Technologies develops technologies for biomedical research and diagnostics. Biotech Stockholm, Sweden Series B $15.5M 2026-08-20 $43.5M Industrifonden, Navigare Ventures, Colibri Ventures +1 11 to 50 2020
5 Octarine Bio Octarine Bio is a synthetic biology company that produces cannabinoids for the pharmaceutical industry. Biotech Copenhagen, Denmark Series A $5.9M 2026-01-22 $15.5M MassChallenge, Vaekstfonden, Unconventional Ventures +2 11 to 50 2018
6 Biomia Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. Biotech Lyngby, Denmark Seed $3.0M 2026-02-09 $3.0M BlueYard Capital, Amino Collective, Nucleus Capital 1 to 10 2022
7 Cellevate Cellevate develops cell culture systems for biotech research and production. Biotech Lund, Sweden Seed $2.2M 2026-03-30 $12.1M European Innovation Council, Industrifonden, Onsight Ventures +1 11 to 50 2014
8 Alcolase Alcolase is a Danish life science start-up developing treatments for alcohol flushing. Biotech Copenhagen, Denmark Seed $1.7M 2026-05-18 $2.6M Antler 1 to 10 2021
9 ENZIDIA ENZIDIA develops enzyme acceleration technology for biomanufacturing. Biotech Kongens Lyngby, Denmark Angel $241K 2026-03-16 $865K Innovation Fund Denmark 1 to 10 2024

Table 2. Biotech startups in the Nordics: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Novo Holdings Corporate venture arm Hellerup, Denmark 6 3% 1 ADCendo
2 Business Finland Government investment office Helsinki, Finland 5 3% 1 Onego Bio
3 European Innovation Council Startup accelerator Brussels, Belgium 5 3% 2 Onego Bio, Cellevate
4 Tesi Government investment office Helsinki, Finland 4 2% 1 Onego Bio
5 Export and Investment Fund Government investment office Hellerup, Denmark 4 2%
6 Vaekstfonden Venture capital firm Hellerup, Denmark 4 2% 1 Octarine Bio
7 Industrifonden Venture capital firm Stockholm, Sweden 3 2% 2 Pixelgen Technologies, Cellevate
8 Voima Ventures Venture capital firm Helsinki, Finland 3 2%
9 BioInnovation Institute Venture Lab Startup accelerator Copenhagen, Denmark 3 2%
10 Chalmers Ventures AB Venture capital firm Gothenburg, Sweden 3 2%
11 Y Combinator Startup accelerator Mountain View, United States 2 1%
12 SmiLe Incubator Startup accelerator Lund, Sweden 2 1% 1 Cellevate
13 Lifeline Ventures Venture capital firm Helsinki, Finland 2 1%
14 Innovation Fund Denmark Government investment office Copenhagen, Denmark 2 1% 1 ENZIDIA
15 BioInnovation Institute Venture House Startup accelerator Copenhagen, Denmark 2 1%

Table 3. Biotech startups in the Nordics: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 139 70% $2.1B
Software 26 13% $152.3M
Artificial intelligence 17 9% $81.1M
Hardware 8 4% $2.2M
Fintech 2 1% $1.4M
Commerce 1 1%
Education 1 1%
Energy 1 1%

Table 4. Biotech startups in the Nordics by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 35 18% $533K
Seed 94 47% $1.7M
Series A 43 22% $11.7M
Series B 16 8% $16.2M
Series C 8 4% $41.0M
Series D+ 2 1% $34.1M

Table 5. Biotech startups in the Nordics by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
Denmark 86 43%
Sweden 66 33%
Finland 30 15%
Norway 13 7%
Iceland 3 2%

Table 6. Biotech startups in the Nordics by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Copenhagen 41 21%
Stockholm 18 9%
Helsinki 14 7%
Gothenburg 11 6%
Aarhus 10 5%
Oslo 9 5%
Solna 8 4%
Lund 8 4%
Lyngby 6 3%
Kongens Lyngby 5 3%
Uppsala 5 3%
Trondheim 4 2%

Table 7. Biotech startups in the Nordics by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 6% $5.8M
October 2026 2 6% $28.4M
September 2026 8 26% $153.6M
August 2026 1 3% $15.5M
July 2026 1 3% $515K
June 2026 2 6% $1.2M
May 2026 1 3% $1.7M
April 2026 2 6% $95.0M
March 2026 5 16% $8.3M
February 2026 2 6% $7.7M
January 2026 2 6% $41.0M
December 2025 3 10% $114.9M

Table 8. Biotech startups in the Nordics: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 28 14% $358.8M
2025 28 14% $464.1M
2024 28 14% $404.7M
2023 19 10% $131.5M
2022 17 9% $119.5M
2021 14 7% $99.4M

Table 9. Biotech startups in the Nordics by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 27 14%
2020 to 2022 48 24%
2015 to 2019 64 32%
2010 to 2014 32 16%
Before 2010 26 13%

Table 10. Biotech startups in the Nordics by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 105 55%
11 to 50 77 40%
51 to 100 5 3%
101 to 250 2 1%
251 to 500 2 1%

Table 11. Biotech startups in the Nordics by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in the Nordics are on the list?
198, in the file dated 16 November 2026. 31 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 198 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in the Nordics: 198 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in the Nordics by funding stage

Other sectors in Nordics

Biotech startups elsewhere

Cite: FundingWatcher, 198 funded biotech companies in the Nordics, 16 November 2026. https://fundingwatcher.com/startups/biotech/nordics/